NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26)
- PMID: 19233143
- DOI: 10.1016/j.bbrc.2009.02.069
NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26)
Abstract
Protein phosphorylation plays critical roles in many regulatory mechanisms controlling cell activities and thus involved in various diseases. The cellular equilibrium of phosphorylation is regulated through the actions of protein kinases and phosphatases. Therefore, these regulatory proteins have emerged as promising targets for drug development. In this study, we screened protein tyrosine phosphatases (PTPs) by in vitro phosphatase assays to identify PTPs that are inhibited by 8-hydroxy-7-(6-sulfonaphthalen-2-yl)diazenyl-quinoline-5-sulfonic acid (NSC-87877), a potent inhibitor of SHP-1 and SHP-2 PTPs. Phosphatase activity of dual-specificity protein phosphatase 26 (DUSP26) was decreased by the inhibitor in a dose-dependent manner. Kinetic studies with NSC-87877 and DUSP26 revealed a competitive inhibition. NSC-87877 effectively inhibited DUSP26-mediated dephosphorylation of p38, a member of mitogen-activated protein kinase (MAPK) family. Since DUSP26 is involved in survival of anaplastic thyroid cancer (ATC) cells, NSC-87877 could be a therapeutic reagent for treating ATC.
Similar articles
-
NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.Cell Death Dis. 2015 Aug 6;6(8):e1841. doi: 10.1038/cddis.2015.207. Cell Death Dis. 2015. PMID: 26247726 Free PMC article.
-
Inhibition of dual-specificity phosphatase 26 by ethyl-3,4-dephostatin: Ethyl-3,4-dephostatin as a multiphosphatase inhibitor.Pharmazie. 2016 Apr;71(4):196-200. Pharmazie. 2016. PMID: 27209699
-
PTP inhibitor IV protects JNK kinase activity by inhibiting dual-specificity phosphatase 14 (DUSP14).Biochem Biophys Res Commun. 2009 Oct 2;387(4):795-9. doi: 10.1016/j.bbrc.2009.07.127. Epub 2009 Jul 29. Biochem Biophys Res Commun. 2009. PMID: 19646420
-
Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?Oncology. 2018;95(5):257-269. doi: 10.1159/000490106. Epub 2018 Jun 20. Oncology. 2018. PMID: 29925063 Review.
-
A Review of DUSP26: Structure, Regulation and Relevance in Human Disease.Int J Mol Sci. 2021 Jan 14;22(2):776. doi: 10.3390/ijms22020776. Int J Mol Sci. 2021. PMID: 33466673 Free PMC article. Review.
Cited by
-
N-Acetyl-seryl-aspartyl-lysyl-proline inhibits ET-1-induced collagen production by preserving Src homology 2-containing protein tyrosine phosphatase-2 activity in cardiac fibroblasts.Pflugers Arch. 2012 Oct;464(4):415-23. doi: 10.1007/s00424-012-1150-7. Epub 2012 Sep 12. Pflugers Arch. 2012. PMID: 22968858 Free PMC article.
-
Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.Blood. 2013 Sep 5;122(10):1822-32. doi: 10.1182/blood-2013-01-482315. Epub 2013 Jul 29. Blood. 2013. PMID: 23896411 Free PMC article.
-
NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.Cell Death Dis. 2015 Aug 6;6(8):e1841. doi: 10.1038/cddis.2015.207. Cell Death Dis. 2015. PMID: 26247726 Free PMC article.
-
Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans.Nat Med. 2019 Nov;25(11):1739-1747. doi: 10.1038/s41591-019-0610-4. Epub 2019 Nov 7. Nat Med. 2019. PMID: 31700183 Free PMC article.
-
Role of Non-Receptor-Type Tyrosine Phosphatases in Brain-Related Diseases.Mol Neurobiol. 2023 Nov;60(11):6530-6541. doi: 10.1007/s12035-023-03487-5. Epub 2023 Jul 17. Mol Neurobiol. 2023. PMID: 37458988 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials